Treatment Outcomes in Anaplastic Thyroid Cancer

<figure class="figure-group responsive"><div class="sub-figure" id="a"><object data="https://static-preview.hindawi.com/articles/jtr/volume-2019/8218949/figures/8218949.fig.002a.svgz" name="8218949.fig.002a" type="image/svg+xml"></object><div class="fig-label">(a) EBRT vs. No EBRT</div></div><div class="sub-figure" id="b"><object data="https://static-preview.hindawi.com/articles/jtr/volume-2019/8218949/figures/8218949.fig.002b.svgz" name="8218949.fig.002b" type="image/svg+xml"></object><div class="fig-label">(b) Surgery vs. no surgery</div></div><div class="sub-figure" id="c"><object data="https://static-preview.hindawi.com/articles/jtr/volume-2019/8218949/figures/8218949.fig.002c.svgz" name="8218949.fig.002c" type="image/svg+xml"></object><div class="fig-label">(c) Chemotherapy vs. no chemotherapy</div></div></figure>

<p>Overall survival for patients who underwent (a) EBRT versus no EBRT, (b) surgery versus no surgery, and (c) chemotherapy versus no chemotherapy.</p>

Journal of Thyroid Research

Treatment Outcomes in Anaplastic Thyroid Cancer

Figure 2